Literature DB >> 15086737

Expression of p27 and p53: comparative analysis of uterine carcinosarcoma and endometrial carcinoma.

A Abargel1, I Avinoach, V Kravtsov, M Boaz, M Glezerman, J Menczer.   

Abstract

The aim of the study was to assess both p27 and p53 expression in the stromal and epithelial component of carcinosarcoma and to assess if their expression in the latter is different than in endometrial carcinoma. Immunohistochemical staining for p27 and p53 was performed on paraffin-embedded tissue blocks of 18 uterine specimens with carcinosarcoma and their expression assessed. Their expression in the epithelial element was also compared to that in 35 paraffin-embedded tissue blocks of endometrial endometrioid carcinoma. Reduced p27 expression was observed in a similarly high proportion of the stromal (77.8%) as well as of the epithelial component (66.7%) of carcinosarcoma. Although statistically not significant, the proportion of reduced p27 expression in endometrial carcinoma (85.7%) was higher than in the epithelial element of carcinosarcoma. The percentage of p53 overexpression in both elements of carcinosarcomas and in endometrial carcinomas was low and also similar (27.8 and 20.0%, respectively). Our results indicate that reduced p27 expression is common and p53 overexpression is infrequent in carcinosarcoma. Their similar rates of expression in the stromal and epithelial elements of the tumor support the contention of a monoclonal origin of carcinosarcoma. Unexpectedly, reduced p27 expression is more common in endometrial carcinoma than in the epithelial element of carcinosarcoma, in spite of the less favorable prognosticators and outcome in the latter. Further studies of p27 expression in carcinosarcoma are indicated to establish its clinical value in this aggressive malignancy.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15086737     DOI: 10.1111/j.1048-891x.2004.014221.x

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  5 in total

1.  Loss of p27 Associated with Risk for Endometrial Carcinoma Arising in the Setting of Obesity.

Authors:  A S McCampbell; M L Mittelstadt; R Dere; S Kim; L Zhou; B Djordjevic; P T Soliman; Q Zhang; C Wei; S D Hursting; K H Lu; R R Broaddus; C L Walker
Journal:  Curr Mol Med       Date:  2016       Impact factor: 2.222

Review 2.  Review of Recommended Treatment of Uterine Carcinosarcoma.

Authors:  Joseph Menczer
Journal:  Curr Treat Options Oncol       Date:  2015-11

3.  A multi-institutional study of outcomes in stage I-III uterine carcinosarcoma.

Authors:  Elizabeth L Dickson; Rachel Isaksson Vogel; Paola A Gehrig; Stuart Pierce; Laura Havrilesky; Angeles Alvarez Secord; Joseph Dottino; Amanda N Fader; Stephanie Ricci; Melissa A Geller
Journal:  Gynecol Oncol       Date:  2015-09-06       Impact factor: 5.482

4.  Clinicopathological characteristics, treatment and outcomes in uterine carcinosarcoma and grade 3 endometrial cancer patients: a comparative study.

Authors:  Jun Zhu; Hao Wen; Rui Bi; Xiaohua Wu
Journal:  J Gynecol Oncol       Date:  2015-10-12       Impact factor: 4.401

5.  Study of the Association of Phosphatase and Tensin Homolog and p27 Expressions in Endometrial Hyperplasia and Carcinoma.

Authors:  Ihab Shafek Atta
Journal:  J Microsc Ultrastruct       Date:  2019 Jul-Sep
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.